{
    "1627729855944048646": {
        "attachments": {
            "media_keys": [
                "13_1627729804396007447"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-02-20T18:00:14.000Z",
        "edit_history_tweet_ids": [
            "1627729855944048646"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 49,
                    "normalized_text": "cancer",
                    "probability": 0.4864,
                    "start": 44,
                    "type": "Other"
                },
                {
                    "end": 99,
                    "normalized_text": "cancer",
                    "probability": 0.401,
                    "start": 94,
                    "type": "Other"
                },
                {
                    "end": 279,
                    "normalized_text": "GU23",
                    "probability": 0.5469,
                    "start": 276,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 280,
                    "start": 275,
                    "tag": "GU23"
                }
            ],
            "urls": [
                {
                    "display_url": "pic.twitter.com/6R3Ls3i4XF",
                    "end": 304,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1627729855944048646/video/1",
                    "media_key": "13_1627729804396007447",
                    "start": 281,
                    "url": "https://t.co/6R3Ls3i4XF"
                }
            ]
        },
        "id": "1627729855944048646",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 6142,
            "like_count": 11,
            "quote_count": 0,
            "reply_count": 2,
            "retweet_count": 3
        },
        "text": "Around 10-20% of men with advanced prostate cancer will develop castration-resistant prostate cancer within five years of diagnosis and the majority will unfortunately succumb to this aggressive disease within two to three years. Know your risk factors \u2013 talk to your doctor #GU23 https://t.co/6R3Ls3i4XF"
    }
}